The DEFR14C https://sec.report/Document/0001607062
Post# of 36536
(Total Views: 753)
Posted On: 05/24/2021 12:34:27 PM
The DEFR14C https://sec.report/Document/0001607062-21-000139/ now makes it very clear why the IPO is taking so long. When the NuGenerex dividend shares began trading on the OTC Pink under NUGX, all the NuGenerex common shares (750 million) would be alluded to by that ticker symbol since NuGenerex had only one common share class. The DEFR14C will now alter the NuGenerex charter to authorize two types of common shares, Class A and Class B each with their own provisions. Once the Classes are created, then NuGenerex can offer the Class B shares to the public, where the company will get the capital funding we know they need.
We also now have a clearer vision of the IPO timeline.
20 days after the DEFR14C shareholder notification + official corporation charter updating + final IPO prep
May 21 – June 10 Notification (calendar not business)
June 11 – June 18 Charter update (pure guess - no real idea on government red tape timelines)
June 21 – June 25 Final IPO prep (pure guess – I am assuming that all major work has or will be done by then)
June 28 – July 2 IPO launch
After the NuGenerex charter change, the two common share classes A & B would need official ticker symbols. Class A (ours) could stay as NUGX, name as good as any, and Class B will be NGIO. Class A NUGX will remain in the OTC Pink. Why, because the Class B NGIO is where NuGenerex will raise their funding. However, NUGX could become very active on the OTC before IPO in anticipation of the IPO because after all they are still valid shares of NuGenerex.
So why would new investors want to buy NGIO shares?
One: NGIO will be listed on NASDAQ (not the OTC)
Two: NGIO will be sold for $9 but have a guarantee liquidation value of $11
Three: NUGX is on the OTC Pink (need I say anymore)
I have been having a PM debate with a very wise person on who gets the IPO Warrants. The IPO S-1 says the NGIO will be sold in Units that have 1 Common B share plus 2 Warrants. The debate is:
Me: Units go from NuGenerex to the Underwriters who keep the Warrants and sell only the Common B shares to IPO buyers
Wise Debater: Units go directly to IPO buyers who get both Common B shares and the Warrants, underwriters are only bystanders?
If anyone gets to talk to Dawson James, please ask about this point. The difference is HUGE since one of the two Warrants allows the owner to get NGIO shares for free under certain circumstances.
We also now have a clearer vision of the IPO timeline.
20 days after the DEFR14C shareholder notification + official corporation charter updating + final IPO prep
May 21 – June 10 Notification (calendar not business)
June 11 – June 18 Charter update (pure guess - no real idea on government red tape timelines)
June 21 – June 25 Final IPO prep (pure guess – I am assuming that all major work has or will be done by then)
June 28 – July 2 IPO launch
After the NuGenerex charter change, the two common share classes A & B would need official ticker symbols. Class A (ours) could stay as NUGX, name as good as any, and Class B will be NGIO. Class A NUGX will remain in the OTC Pink. Why, because the Class B NGIO is where NuGenerex will raise their funding. However, NUGX could become very active on the OTC before IPO in anticipation of the IPO because after all they are still valid shares of NuGenerex.
So why would new investors want to buy NGIO shares?
One: NGIO will be listed on NASDAQ (not the OTC)
Two: NGIO will be sold for $9 but have a guarantee liquidation value of $11
Three: NUGX is on the OTC Pink (need I say anymore)
I have been having a PM debate with a very wise person on who gets the IPO Warrants. The IPO S-1 says the NGIO will be sold in Units that have 1 Common B share plus 2 Warrants. The debate is:
Me: Units go from NuGenerex to the Underwriters who keep the Warrants and sell only the Common B shares to IPO buyers
Wise Debater: Units go directly to IPO buyers who get both Common B shares and the Warrants, underwriters are only bystanders?
If anyone gets to talk to Dawson James, please ask about this point. The difference is HUGE since one of the two Warrants allows the owner to get NGIO shares for free under certain circumstances.
(9)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼